News

Eviden Dominates Green500 List with Top Energy-Efficient Supercomputers

Eviden Dominates Green500 List with Top Energy-Efficient Supercomputers

Introduction to Eviden's Supercomputers

Eviden, a renowned leader in advanced computing technologies, has made headlines by securing the top two spots on the prestigious Green500 list for energy efficiency. This ranking reflects the exceptional capabilities of Eviden’s supercomputers, which have been recognized not only for their computational power but also for their commitment to sustainability.

The Importance of Energy Efficiency in Computing

In recent years, the demand for high-performance computing has skyrocketed, primarily driven by the rapid advancements in artificial intelligence and data analytics. However, this surge in computational power often results in increased energy consumption. As a response, the industry is now prioritizing energy efficiency, which is crucial for creating sustainable technological solutions. Eviden’s focus on energy-efficient designs in its supercomputers sets a new standard in the landscape of high-performance computing.

The Green500 Achievements

The Green500 list ranks the most energy-efficient supercomputers globally, and Eviden proudly boasts three of its systems within the top ten, highlighting its innovative technologies. The noteworthy systems are powered by Eviden’s patented Direct Liquid Cooling technology. This advanced cooling method utilizes warm water, achieving remarkable heat dissipation rates exceeding 97%, which contributes significantly to energy savings.

Top Systems of Eviden

Among the top two supercomputers, the first-ranked system is the JEDI module of Europe's inaugural exascale supercomputer, JUPITER, which was acquired through a collaboration with the EuroHPC Joint Undertaking. This cutting-edge system has reaffirmed Eviden’s position at the forefront of the computing industry in terms of performance and sustainability.

The Second Ranking System

The second spot on the Green500 has been awarded to the ROMEO 2025 supercomputer, located at the French University of Reims Champagne-Ardenne (URCA). This recognition underlines the effectiveness of Eviden's unique technologies in achieving top performance while maintaining energy efficiency.

Broader Impact on the Industry

Eviden's success on the Green500 profoundly impacts the global focus on sustainable computing. The elevation of their supercomputers not only emphasizes the importance of energy efficiency but also inspires other organizations in the technology sector to enhance their sustainability efforts. With this recognition, Eviden reinforces its dedication to minimizing environmental impact while providing robust computational solutions.

Commitment to Sustainable Technology

Bruno Lecointe, the Global Head of HPC, HPC-AI, and Quantum Computing at Eviden, expressed pride in the company’s accomplishments, stating that leading the Green500 list is a testament to Europe's leadership in high-performance computing. He emphasized the essential role of sustainable practices in shaping the future of technology.

New Entrants to TOP500

The TOP500 list, which ranks the most powerful supercomputers globally, has also welcomed recent additions, such as France’s HPC-AI Jean Zay system, ranked 27th, and Germany’s latest JETI module for Europe’s first exascale JUPITER, ranked 18th. This inclusion highlights Eviden's ongoing commitment to innovation and advancement in high-performance computing.

About Eviden

Eviden stands as a next-generation technology leader, specializing in data-driven, trusted digital transformation. The company operates worldwide, demonstrating expertise across diverse sectors. With approximately 41,000 professionals, Eviden aims to push the boundaries of technology to enable a sustainable future.

About Atos Group

Atos Group, the parent company of Eviden, remains committed to providing tailored digital transformation solutions across industries. With a workforce of around 82,000, Atos excels in enhancing digital security and computing, contributing to a decarbonized future for its clients.

Frequently Asked Questions

What is the significance of the Green500 list?

The Green500 list ranks the most energy-efficient supercomputers, promoting the importance of sustainable computing technologies.

How does Eviden's technology contribute to energy efficiency?

Eviden's supercomputers utilize innovative cooling technologies, like Direct Liquid Cooling, to achieve higher energy efficiency in computing.

Who are the major players in the high-performance computing market?

Eviden, as part of Atos Group, is a leading player in high-performance computing, renowned for its advancements in technology and sustainability.

What is Eviden's approach to sustainability?

Eviden is dedicated to minimizing environmental impact through energy-efficient practices in the design and operation of its technologies.

How do recent developments in supercomputing impact the industry?

Developments like Eviden's leading status in the Green500 encourage the entire tech industry to prioritize energy efficiency and sustainability in their products.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

TechCrunch Disrupt 2026: NYSE and Snowflake Highlights

Updated Category News Views 21

Ever noticed how the air vibrates just a bit more when major players like NYSE and Snowflake start shaking hands at big-league events like TechCrunch Disrupt? You'd better believe we're seeing a fresh brew of opportunities and challenges in the market as these titans lock horns and share insights. It's no small feat when the financial nerve center partners into the tech...

Continue Reading
Paradigm Therapeutics: A Beacon in Rare Diseases

Updated Category News Views 4

A Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...

Continue Reading
Partner Valuation Advisors Bolsters Team with Eichman

Updated Category News Views 7

Eichman Joins Partner Valuation Advisors as MD Turns out the buzz in real estate appraisal isn’t just about property values these days; it's about who's valuing them. Just ask Partner Valuation Advisors, who are realigning their chess pieces by bringing seasoned pro Justin Eichman, MAI, on board as Managing Director. Talk about playing your cards right. A Heavyweight in...

Continue Reading
Skiptown Expands in Georgia Amid Growing Demand

Updated Category News Views 24

With the pet care industry barking up a storm lately, Skiptown is ramping up efforts to expand its presence in Georgia. The tech-enabled dog care franchise already has a paw print in Atlanta, but it's sniffing out new opportunities across the state. Now they're on the hunt for franchise owners who can bring this modern approach to more communities. Why Georgia? The Growth...

Continue Reading
Think Tank Pushes for Bold Parkinson's Prevention Plan

Updated Category News Views 25

A New Era for Parkinson's Disease Prevention The Parkinson's Foundation has rolled out its battle plan to take on Parkinson's disease from the ground up, shifting gears from managing symptoms to stopping the illness before it starts. It's about damn time, too. With the disease being the fastest-growing neurodegenerative disorder and impacting 10 million people worldwide,...

Continue Reading
Veterans Transitioning to Real Estate with Scholarships

Updated Category News Views 15

Tapping Military Skills for Civilian Gain Finding a new career after military service is a mountain of a task, but veterans now have a golden ticket into the real estate appraisal world. The Appraisal Institute's Next Mission Scholarship is throwing veterans a $1,000 life preserver to dive into a field where their military-honed skills already shine. The Power of a...

Continue Reading
Special Needs Group Partners with MAST to Enhance Accessibility

Updated Category News Views 22

Accessible Travel Takes the Spotlight Ah, the travel biz—just when you think you’ve got it all figured out, along comes a partnership like this to shake things up. Special Needs Group, the big cheese in mobility and medical equipment rentals, is teaming up with MAST Travel Network. Together, they're rolling out initiatives to make the world a bit more accessible, even...

Continue Reading
Omneky Outshines Competitors in AI Ad Scoring

Updated Category News Views 33

Brewing a better ad with AI isn't just about the model you plug in—it's about the wizardry wrapping around it. Omneky's latest caper in the AI advertising game has snagged the spotlight, pulling a hearty 8.8 taste score on a recent TasteBench comparison. That's not a minor tweak, folks, but a whopping 1.2-point lead over the shadow-chasing curves of the next...

Continue Reading
New Data on SKYRIZI Offers Hope for Crohn's Patients

Updated Category News Views 16

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Continue Reading
Honeywell Aerospace Faces Legal Turbulence in Fraud Case

Updated Category News Views 7

If you've got your chips on Honeywell Aerospace, Inc. (HONA), buckle up because things are getting choppy. Investors who took a bath on their shares now have the chance to put on their legal gloves and join a securities fraud class action lawsuit against the company. Legal Storm Over Misleading Statements Here's the rub: Between June 29 and September 1, 2026, the folks at...

Continue Reading

Top 5 Most Recently Viewed Articles

Pieridae Energy Limited Reports Strong Q3 2024 Performance

Updated Category News Views 58

Strong Financial and Operational Results from Pieridae Energy CALGARY, Alberta - Pieridae Energy Limited (“Pieridae” or the “Company”) (TSX: PEA) has announced its third quarter 2024 financial and operating results, showcasing an impressive production output and robust financial performance. The company achieved a production rate of 23,116 barrels of oil...

Continue Reading
Atea Pharmaceuticals Showcases Promising HCV Treatment Data

Updated Category News Views 136

Innovation in Hepatitis C Treatment by Atea Pharmaceuticals Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) has made a significant impact in the field of antiviral therapeutics through their ongoing research and development efforts. The company recently presented compelling data at The Liver Meeting 2024, highlighting the promising combination of bemnifosbuvir and ruzasvir for...

Continue Reading
Study Confirms Safety of Combined Eye Drops for Surgery Use

Updated Category News Views 172

Introduction to the Study A five-year pharmacovigilance study has confirmed the excellent safety profile of a fixed-dose combination eye drop developed by NTC. This eye drop combines an anti-inflammatory steroid and a quinolone antibiotic, designed for preventing and treating inflammation, as well as preventing infection after cataract surgery. Study Overview The findings...

Continue Reading
New Concerns Arise for Roblox Amid Allegations of Misreported Metrics

Updated Category News Views 203

Allegations Against Roblox: A Closer Look Roblox Corp (NYSE: RBLX) has recently come under fire after a report from Hindenburg Research highlighted potential discrepancies in its reported user metrics, leading to a notable decline in its stock prices. The gaming platform is being questioned for allegedly overstating its user metrics, including daily active users (DAUs)...

Continue Reading
uniQure N.V. Faces Investigation Amid Securities Fraud Concerns

Updated Category News Views 155

Understanding the uniQure N.V. Investigation Currently, uniQure N.V. is under investigation concerning possible violations of securities laws. This inquiry has raised significant concerns for shareholders and potential investors, driving many to seek assistance in understanding their rights moving forward. The investigation is being led by the DJS Law Group, an...

Continue Reading